STK11 and melanoma: In addition, Pten or Nf1 loss abrogates BrafV600E‐induced oncogene‐induced senescence (OIS) and leads to in vivo melanoma formation and Lkb1 loss abrogates BrafV600E‐induced cell growth arrest without full progression to malignancy [10, 11, 37].